Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dss (DSS) Cash & Equivalents (2016 - 2025)

Dss has reported Cash & Equivalents over the past 16 years, most recently at $6.2 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 45.64% year-over-year to $6.2 million; the TTM value through Dec 2025 reached $6.2 million, down 45.64%, while the annual FY2025 figure was $6.2 million, 45.64% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $6.2 million at Dss, down from $11.4 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $69.5 million in Q3 2021 and troughed at $6.2 million in Q4 2025.
  • A 5-year average of $34.9 million and a median of $33.4 million in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: surged 1269.31% in 2021 and later tumbled 74.48% in 2023.
  • Year by year, Cash & Equivalents stood at $56.6 million in 2021, then crashed by 71.41% to $16.2 million in 2022, then tumbled by 59.11% to $6.6 million in 2023, then surged by 72.8% to $11.4 million in 2024, then crashed by 45.64% to $6.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for DSS at $6.2 million in Q4 2025, $11.4 million in Q4 2024, and $6.6 million in Q4 2023.